<?xml version="1.0" encoding="UTF-8"?>
<p id="Par15">With these new pediatric data, there are seemingly more questions than answers to the variability of the results between the pediatric cohorts. The authors of the studies and associated editorials question what contributes to the variability in results hypothesizing that it could be due to differences in immune microenvironment, vaccine substrains used, how the samples were handled, the test used, and potential difference in vaccine handling
 <sup>
  <xref ref-type="bibr" rid="CR33">33</xref>,
  <xref ref-type="bibr" rid="CR61">61</xref>,
  <xref ref-type="bibr" rid="CR63">63</xref>,
  <xref ref-type="bibr" rid="CR64">64</xref>
 </sup>. Furthermore, in both Ghana and Brazil, the authors questioned whether or not children had received another dose of the vaccine as the proportion seropositive was higher at later time points
 <sup>
  <xref ref-type="bibr" rid="CR33">33</xref>,
  <xref ref-type="bibr" rid="CR34">34</xref>
 </sup>.
</p>
